基于差异基因表达谱分析揭示血塞通注射液抗脑缺血再灌注损伤机制
本研究通过生物信息学分析GSE61616数据集筛选8066个差异表达基因,结合MCAO大鼠实验验证,发现血塞通注射液通过上调BDNF及其受体TrkB减轻脑缺血再灌注损伤,BDNF敲低可消除其神经保护作用。
要点
- 血塞通注射液可能通过激活BDNF-TrkB通路发挥神经保护作用。
- MAPK信号通路是差异基因最显著富集的通路。
- BDNF是节点度最高的核心基因,其敲低可 abolish 血塞通的体内效应。
核心结论
- 血塞通注射液通过BDNF-TrkB通路减轻脑缺血再灌注损伤,发挥神经保护作用。
研究设计与样本
- 生物信息学分析GSE61616数据集筛选差异表达基因,并在MCAO大鼠中验证核心基因表达及血塞通效应。
主要发现
- 共筛选出8066个差异表达基因,profile 8中基因表达具有临床意义。
- MAPK信号通路在profile 8中显著富集,Bdnf为节点度最高的核心基因。
- 动物实验显示血塞通减轻CIR损伤,升高BDNF及TrkB水平。
- siRNA敲低BDNF可消除血塞通对脑损伤、神经变性和凋亡的体内效应。
关键数值与推荐
- 共筛选出8066个差异表达基因;MAPK信号通路为profile 8中最显著富集通路;Bdnf为节点度最高的核心基因。
临床怎么用
- 血塞通注射液可能通过BDNF-TrkB通路发挥脑缺血再灌注损伤保护作用,为临床用于缺血性卒中提供机制线索。
局限性
- 研究基于生物信息学分析与MCAO大鼠实验验证,尚需进一步临床研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Xuesaitong injection (XST), a well-known traditional Chinese patent medicine, has been widely used in the treatment of cardiovascular and cerebrovascular diseases. The exact mechanisms of XST in ischemic stroke remain to be thoroughly elucidated. PURPOSE: This study aims to characterize the candidate differentially expressed genes (DEGs) and pathways of XST in ischemic stroke by bioinformatics analysis, and to explore new clues for the underlying mechanisms of XST. METHODS: A dataset (GSE61616) was performed to screen out DEGs for deep analysis. Series Test of Cluster analysis for DEGs was carried out. For all DEGs, Gene Ontology (GO) annotation analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed for visualization. The screened hub gene expression characteristics were verified in middle cerebral artery occlusion (MCAO) rats. In vivo studies have demonstrated the mechanisms of XST against cerebral ischemia-reperfusion (CIR) injury. RESULTS: A total of 8066 DEGs were screened out and the expression of genes in profile 8 was suggested to have clinical significance. The MAPK signaling pathway was indicated as the most significantly enriched pathway in profile 8. Bdnf was identified as the most significant hub gene according to node degree. Animal experiments demonstrated that XST attenuated CIR injury. XST increased brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B (TrkB) levels in MCAO. Furthermore, the knockdown of BDNF by siRNA abolished the in vivo effects of XST on brain injury, neurodegeneration and apoptosis after CIR. CONCLUSION: The integrated strategy, based on bioinformatics analyses with experimental verification, provides a novel cellular mechanism by which XST alleviates CIR injury. The BDNF-TrkB pathway was highly thought to play a vital role in the neuroprotective effects of XST.
引用
- Zhang Y, Zhang T, Jia J, et al. Analysis of differential gene expression profiles uncovers mechanisms of Xuesaitong injection against cerebral ischemia-reperfusion injury. Phytomedicine. 2022. PMID: 35691081. doi:10.1016/j.phymed.2022.154224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。